[in Japanese] - 薬剤疫学 被引量: 1发表: 2003年 Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC). 721Background: The oral multikinase inhibitor regorafenib (REG) was approved for unresectable mCRC in Japan in 2013...
[in Japanese] - 薬剤疫学 被引量: 1发表: 2003年 Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC). 721Background: The oral multikinase inhibitor regorafenib (REG) was approved for unresectable mCRC in Japan in 2013...
[in Japanese] - 薬剤疫学 被引量: 1发表: 2003年 Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC). 721Background: The oral multikinase inhibitor regorafenib (REG) was approved for unresectable mCRC in Japan in 2013...
[in Japanese] - 薬剤疫学 被引量: 1发表: 2003年 Postmarketing Surveillance (PMS) Using the Bellco- LYMPHYA System in Predilution HDF Mode Compared with Standard Onl-Line Hemodiafiltration in Predilution P Ahrenholz,RE Winkler 被引量: 0发表: 2013年 ...
[in Japanese] - 薬剤疫学 被引量: 1发表: 2003年 Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabig... A post-marketing surveillance (PMS) study is being conducted to investigate the safety...